Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program.
BMC Cancer
; 19(1): 55, 2019 Jan 11.
Article
en En
| MEDLINE
| ID: mdl-30634942
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Neoplasias del Sistema Biliar
/
Protocolos de Quimioterapia Combinada Antineoplásica
Idioma:
En
Revista:
BMC Cancer
Asunto de la revista:
NEOPLASIAS
Año:
2019
Tipo del documento:
Article